(NASDAQ: QTTB) Q32 Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 56.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 101.52%.
Q32 Bio's earnings in 2025 is -$52,304,000.On average, 4 Wall Street analysts forecast QTTB's earnings for 2025 to be -$40,503,400, with the lowest QTTB earnings forecast at -$49,500,361, and the highest QTTB earnings forecast at -$30,353,765. On average, 4 Wall Street analysts forecast QTTB's earnings for 2026 to be -$54,463,571, with the lowest QTTB earnings forecast at -$61,142,985, and the highest QTTB earnings forecast at -$46,619,285.
In 2027, QTTB is forecast to generate -$69,996,014 in earnings, with the lowest earnings forecast at -$67,801,663 and the highest earnings forecast at -$71,465,826.